The nixed grants appear to be the first the Department of Energy has confirmed from a list that outlines $20 billion in potential cuts. The Department of Energy has canceled more than $700 million in ...
What if you could transform the way you tackle complex tasks, making them not only manageable but seamless? Imagine having a single, organized hub where your ideas, files, and instructions come ...
Beat boredom with over 40 fun and easy crochet projects! Each comes with free step-by-step tutorials, perfect for beginners or anyone looking for creative DIY ideas. #CrochetProjects #DIYCrochet ...
The Department of Energy is cancelling more than $7 billion in funding for hundreds of projects that the agency said don't address the country's energy needs and aren't economically viable. The DOE ...
J S Link America Inc. plans to invest approximately $223 million to establish a new rare earth permanent magnet manufacturing facility in Columbus, Georgia. The new facility will create more than 520 ...
OpenAI has announced that it's making its Projects feature available to free users of ChatGPT. Projects let you organize chats with the company's AI assistant around a specific subject, and were ...
Hosted on MSN
How to Create Projects, Edits, and Templates in Tracktion Waveform Free & Pro Tutorial?
#HomeStudio #MusicProduction #FreeDAW Create projects, templates, and edits plus learn how to backup your projects so you can bring them to other computers. This Waveform tutorial is part of the free ...
On July 22, 2025, the U.S. Food and Drug Administration issued a Complete Response Letter for RP1, delaying potential commercialization and revenue. Research and development expenses increased 34.6% ...
Shares of Replimune (NASDAQ:REPL) plunged ~38% in the premarket on Monday after Stat News reported that the FDA’s top regulator of cancer drugs intervened during the review of the company’s lead asset ...
Replimune (NASDAQ:REPL) climbed more than 100% on Wednesday as Cantor Fitzgerald upgraded the cancer drug developer, citing a potential reversal of an FDA decision that rejected its lead drug ...
SAN FRANCISCO, July 28, 2025 (GLOBE NEWSWIRE) -- A securities class action lawsuit, styled Jboor v. Replimune Group, Inc., et al., No. 1:25-cv-12085 (D. Mass.), has been filed and seeks to represent ...
NEW YORK--(BUSINESS WIRE)--Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Replimune Group, Inc. (NASDAQ: REPL) for potential violations of the federal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback